Search - tctmd.com

Displaying 21 - 40 of 163

Sort: Relevancy | Date

Cardiology Consults Tied to Better Outcomes in Patients With HF

Todd Neale

May 19, 2025

News Featured Fellow

Aditya Mehta, MBBS

Yael L. Maxwell

April 10, 2025

News Conference News ACC 2025

FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints

L.A. McKeown

April 03, 2025

News Conference News ACC 2025

Tight Fluid Restriction Not Needed in Chronic HF Patients: FRESH-UP

Michael O'Riordan

April 01, 2025

News Conference News ACC 2025

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

Caitlin E. Cox

March 30, 2025

News Conference News THT 2025

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

Todd Neale

February 19, 2025

News Daily News

Is It Time for an ‘Interventional Heart Failure’ Subspecialty?

Yael L. Maxwell

February 19, 2025

News Opinion CV Team Dispatch

February 2025 Dispatch for the CV Team

L.A. McKeown

February 01, 2025

News Daily News

Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit

Michael O'Riordan

January 13, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2024

Shelley Wood

December 03, 2024

News Conference News AHA 2024

REALIZE-K: Potassium Binder Boosts MRA Use in Hyperkalemic HFrEF Patients

L.A. McKeown

November 22, 2024

News Conference News AHA 2024

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

Shelley Wood

November 17, 2024

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

Presentation TCT 2024

Managing a Difficult Triad: RHF, RV Dysfunction, and Severe TR

Presenter: Alexander Lauten

October 30, 2024

News Conference News HFSA 2024

‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF

Michael O'Riordan

October 03, 2024

News Conference News HFSA 2024

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

Michael O'Riordan

October 02, 2024

News Conference News ESC 2024

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

Michael O'Riordan

August 30, 2024

News Daily News

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

L.A. McKeown

August 13, 2024

News Daily News

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Todd Neale

June 26, 2024

News Daily News

Vutrisiran, an siRNA for ATTR-CM, Meets Primary Endpoint in HELIOS-B

Michael O'Riordan

June 24, 2024

Advertisement

Cardiology Consults Tied to Better Outcomes in Patients With HF

Aditya Mehta, MBBS

FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints

Tight Fluid Restriction Not Needed in Chronic HF Patients: FRESH-UP

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

Is It Time for an ‘Interventional Heart Failure’ Subspecialty?

February 2025 Dispatch for the CV Team

Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit

TCTMD’s Top 10 Most Popular Stories for November 2024

REALIZE-K: Potassium Binder Boosts MRA Use in Hyperkalemic HFrEF Patients

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Managing a Difficult Triad: RHF, RV Dysfunction, and Severe TR

‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Vutrisiran, an siRNA for ATTR-CM, Meets Primary Endpoint in HELIOS-B

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content